Dr. Deepak L. Bhatt will deliver the 12th H.J.C. Swan Memorial Lecture at the Opening Ceremony, Int'l Academy of Cardiology, 23rd World Congress on Heart Disease, July 27, 2018, Boston, MA, USA
The four hundred twenty-two scientific studies that were selected for presentation assure that the meeting will be a major scientific event. (Dr. Asher Kimchi, July 2018)
BEVERLY HILLS, Calif. (PRWEB) July 23, 2018
Asher Kimchi, M.D., Founder and Chairman of the International Academy of Cardiology, today announced the selection of Deepak L. Bhatt MD, MPH, Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School, Boston, MA, USA, to deliver the Twelfth H.J.C. Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, Annual Scientific Sessions 2018, 23rd World Congress on Heart Disease, to be held in Boston, MA, USA from Friday, July 27 through Sunday, July 29, 2018.
Dr. Bhatt will present on the topic of “Evolving Landscape of Antithrombotic Therapy for Atherosclerosis.”
Aspirin remains the foundation of antiplatelet therapy. Trials soon to report will clarify its role in primary prevention. The role of aspirin in secondary prevention seems quite secure, though recent data have raised concerns about whether the enteric coating might impede its absorption and antiplatelet effects.
Clopidogrel, now generic, remains in common use worldwide for high risk secondary prevention, as monotherapy in patients with myocardial infarction, ischemic stroke, or symptomatic peripheral artery disease. It also remains an important part of dual antiplatelet therapy after stenting in stable coronary artery disease.
In acute coronary syndromes, dual antiplatelet therapy seems particularly important for at least a year of therapy, regardless of whether patients are treated with stents or medical therapy; ticagrelor is being used instead of clopidogrel in patients at low bleeding risk.
The combination of aspirin with low dose rivaroxaban may soon provide an additional option for stable coronary or peripheral artery disease.
Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2018. He was selected by Brigham and Women’s Hospital as the 2014 Eugene Braunwald Scholar. He has over 1100 publications and is listed as a Thomson Reuters Highly Cited Researcher. He is Editor of "Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease." Dr. Bhatt obtained his undergraduate science degree as a National Merit Scholar at the Massachusetts Institute of Technology. He received his medical doctorate from Cornell University. He completed a Master in Public Health with a concentration in clinical effectiveness at Harvard University. His residency in internal medicine was performed at the Hospital of the University of Pennsylvania, and his cardiovascular training was at Cleveland Clinic.
Dr. Asher Kimchi comments, “We are most fortunate to have Dr. Bhatt with us at the 23rd World Congress on Heart Disease. His teachings and research are unparalleled and we are looking forward to his presentation on ‘Evolving Landscape of Antithrombotic Therapy for Atherosclerosis.’”
Asher Kimchi, M.D., is the Co-Medical Director of the Preventive and Consultative Heart Center at the Cedars-Sinai Smidt Heart Institute, Los Angeles, California. He is also a Clinical Professor of Medicine at Cedars-Sinai Medical Center and at the David Geffen School of Medicine at UCLA, Los Angeles, California.
On Friday, July 27, 2018, at 9:00 am, the Founder and Chairman of the International Academy of Cardiology, Dr. Asher Kimchi, will greet the Congress’ attendees from thirty-six countries at the Opening Ceremony of the 23rd World Congress on Heart Disease.
The Opening Ceremony and Awards Presentations will be chaired by Dr. John A. Elefteriades, New Haven, CT, USA; Professor of Cardiothoracic Surgery and Director of the Aortic Institute at Yale University and Yale-New Haven Hospital; Chairman of the Scientific Executive Committee and Chairman of the Section of Cardiovascular Surgery, International Academy of Cardiology.
The following Members of the International Academy of Cardiology will also take part in the Opening Ceremony:
- Dr. Jeffrey Borer, Brooklyn, NY, USA; Professor of Medicine, Cell Biology, Radiology and Surgery, at the SUNY Downstate Medical Center and College of Medicine, and Director of the Howard Gilman Institute for Heart Valve Disease; Member of the Scientific Executive Committee and Chairman of the Section of Valvular Heart Disease, International Academy of Cardiology
- Prof. Naranjan S. Dhalla, Canada, Distinguished Professor and Director of Cardiovascular Developments, SBRC, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada; Member of the Scientific Executive Committee and Chairman of the Section of Molecular Cardiology, International Academy of Cardiology
- Prof. Wilbert S. Aronow, Valhalla, NY, USA; Professor of Medicine and Director of Cardiology Research, Westchester Medical Center and New York Medical College; Member of the Scientific Executive Committee and Chairman of the Section of Hypertension, International Academy of Cardiology
- Prof. Samia Mora, Boston, MA, USA; Associate Professor of Medicine, Harvard Medical School; Director of the Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham and Woman’s Hospital; Member of the Scientific Executive Committee and Chairman of the Section of Preventive Cardiology, International Academy of Cardiology
Awards to be Presented for Distinguished Contributions to Medicine and Cardiology:
The International Academy of Cardiology has established five awards to honor the memory of distinguished colleagues who made a major contribution to Medicine and Cardiology and who were members of the faculty for previous International Academy of Cardiology meetings. As in previous years, a very prestigious Awards Committee selected the recipients.
Dr. John A. Elefteriades, Chairman of the Awards Committee, will present the following awards for 2018 at the Opening Ceremony of the Congress:
- The WALTER BLEIFELD MEMORIAL AWARD for distinguished work in the field of Clinical Research
- The ALBRECHT FLECKENSTEIN MEMORIAL AWARD for distinguished work in the field of Basic Research
- The JAN J. KELLERMANN MEMORIAL AWARD for distinguished work in the field of Cardiovascular Disease Prevention
- The HANS-PETER KRAYENBUEHL MEMORIAL AWARD for distinguished work in the field of Research in Cardiac Function
- The MELVIN L. MARCUS MEMORIAL AWARD for distinguished contribution as a Gifted Teacher
The International Academy of Cardiology has established DISTINGUISHED FELLOWSHIP AWARDS for profound contribution to Cardiovascular Medicine and important service to the Academy. The awards will be presented to faculty members at the Opening Ceremony.
The KANU CHATTERJEE LIFETIME ACHIEVEMENT AWARD for outstanding contributions to the field of Cardiovascular Medicine will also be presented during the Opening Ceremony.
Dr. Kimchi notes that, “The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of Molecular and Cellular Cardiology, Cardiac Imaging, Coronary Artery Disease, Peripheral Arterial Disease, Interventional Cardiology, Lipoprotein Disorders, Hypertension, Metabolic Syndrome, Diabetes Mellitus, Heart Failure, Valvular Heart Disease, Diseases of the Aorta, Cardiac Arrhythmias and Electrophysiology, Congenital Heart Disease, Cardiac Surgery, and Measurement of Outcome and Quality of Cardiovascular Care."
According to Dr. Kimchi, "Many distinguished cardiologists and scientists have joined the faculty and will take part in this Congress. Papers will be presented in the form of plenary sessions, symposia and posters and will include superb scientific material that was carefully selected by the Scientific Abstract Review committee from over six hundred abstracts, originating from laboratories in 41 countries. The four hundred twenty-two scientific studies that were selected for presentation assure that the meeting will be a major scientific event."
Presented abstracts were published in a special online supplement issue of the journal, CARDIOLOGY, published by S. Karger AG, Basel, Switzerland. https://www.karger.com/Article/Abstract/491714 (Cardiology 2018;140(suppl 1) 1-438, International Academy of Cardiology, Annual Scientific Sessions 2018, 23rd World Congress on Heart Disease)
Dr. Kimchi proudly announced, “The World Congress on Heart Disease has been endorsed by most prestigious medical societies and associations. The scientific program of the Congress has been reviewed by the American Medical Association and approved for 23 AMA PRA Category 1 Credits™. The Congress is affiliated with the American College of Cardiology, California Chapter, the American Society for Preventive Cardiology, and the International Academy of Cardiovascular Sciences.”
The International Academy of Cardiology, founded twenty-nine years ago by Dr. Asher Kimchi, is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
Registration for the 23rd World Congress on Heart Disease, presented by the International Academy of Cardiology, in Boston, MA, USA from July 27 – 29, 2018 is available online at http://www.CardiologyOnline.com. The Congress takes place at the Westin Copley Place, 10 Huntington Avenue, Boston, MA, USA.
For further information or to book interviews, please contact Cirina Catania at The Catania Group, news(at)catania.us, or the International Academy of Cardiology (IAC), klimedco(at)ucla(dot)edu.
IAC on Facebook: https://www.facebook.com/IACardiology/
IAC on Twitter: https://twitter.com/iacardiology
IAC on YouTube: https://tinyurl.com/y88r29ef
IAC on Instagram: https://www.instagram.com/iacardiology/
